Cargando…

Evolving Treatment Options for Cancer-Related Venous Thromboembolism

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Attia, Doaa, Khorana, Alok A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352229/ https://www.ncbi.nlm.nih.gov/pubmed/34396251 http://dx.doi.org/10.1016/j.jaccao.2020.06.003

Ejemplares similares

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
por: Bauersachs, Rupert, et al.
Publicado: (2020)

Guidance for the prevention and treatment of cancer-associated venous thromboembolism
por: Khorana, Alok A., et al.
Publicado: (2016)

RNA expression and risk of venous thromboembolism in lung cancer
por: Sussman, Tamara A., et al.
Publicado: (2019)

Prevention of venous thromboembolism in ambulatory patients with cancer
por: Khorana, Alok A, et al.
Publicado: (2020)

Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review
por: Gervaso, Lorenzo, et al.
Publicado: (2021)

Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer
por: Streiff, Michael B., et al.
Publicado: (2018)

Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated with Mortality in Patients with Prostate Cancer
por: Chaturvedi, Shruti, et al.
Publicado: (2014)

Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States
por: Khorana, Alok A, et al.
Publicado: (2013)

Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis
por: Delluc, Aurélien, et al.
Publicado: (2020)

COVID‐19 and venous thromboembolism: A narrative review
por: Angelini, Dana E., et al.
Publicado: (2022)

Biomarker signatures in cancer patients with and without venous thromboembolism events: a substudy of CASSINI
por: Khorana, Alok A., et al.
Publicado: (2022)

CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients
por: Lee, Agnes YY, et al.
Publicado: (2013)

Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
por: Caroti, Kimberly Snow, et al.
Publicado: (2023)

Treatment options for venous thromboembolism: lessons learnt from clinical trials
por: McRae, Simon
Publicado: (2014)

Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer
por: Khorana, Alok A, et al.
Publicado: (2023)

Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism
por: Coleman, Craig I., et al.
Publicado: (2023)

Management of Venous Thromboembolism in Children: Current Recommendations and Therapeutic Options
por: Bosch, Alessandra, et al.
Publicado: (2020)

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
por: Farge, Dominique, et al.
Publicado: (2022)

Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US Program
por: Caroti, Kimberly Snow, et al.
Publicado: (2023)

Patient Satisfaction With Venous Thromboembolism Treatment
por: Webb, David, et al.
Publicado: (2019)

Prophylaxis and treatment of COVID-19 related venous thromboembolism
por: Kaptein, F.H.J., et al.
Publicado: (2021)

Therapeutic options for the treatment of venous thromboembolism in case of warfarin intolerance: Effects of novel oral anticoagulants
por: Kodani, Eitaro
Publicado: (2013)

Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: review of the literature on current practice and emerging options
por: Ay, Cihan, et al.
Publicado: (2017)

Risk Assessment for Cancer-Associated VTE: Diversifying the Evidence Base
por: Khorana, Alok A.
Publicado: (2021)

Real-world features associated with cancer-related venous thromboembolic events
por: Peippo, Maija Helena, et al.
Publicado: (2018)

A Risk of Venous Thromboembolism Algorithm as a Predictor of Venous Thromboembolism in Patients with Colorectal Cancer
por: Chen, Ying, et al.
Publicado: (2021)

Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial
por: Khorana, Alok A., et al.
Publicado: (2017)

Prevention and treatment of venous thromboembolism
por: Casadei, Barbara, et al.
Publicado: (2020)

Pharmacological cancer treatment and venous thromboembolism risk
por: Muñoz Martín, Andrés J, et al.
Publicado: (2020)

Treatment and secondary prevention of venous thromboembolism in cancer
por: Coleman, R, et al.
Publicado: (2010)

Venous Thromboembolism in Patents With Lung Cancer
por: Suzuki, Takahito, et al.
Publicado: (2020)

Epidemiology of Venous Thromboembolism After Second Cancer
por: Gade, Inger Lise, et al.
Publicado: (2020)

Addition of aspirin to venous thromboembolism chemoprophylaxis safely decreases venous thromboembolism rates in trauma patients
por: Lammers, Daniel, et al.
Publicado: (2023)

Pulmonary Thromboembolism in COVID-19: Venous Thromboembolism or Arterial Thrombosis?
por: Cavagna, Enrico, et al.
Publicado: (2020)

Venous thromboembolism and cancer risk
por: Sandén, Per, et al.
Publicado: (2016)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Chronic thromboembolic pulmonary hypertension: the evolving treatment landscape
por: Kim, Nick H., et al.
Publicado: (2015)

Risk of venous thromboembolism in Chinese pregnant women: Hong Kong venous thromboembolism study
por: Huang, Duo, et al.
Publicado: (2019)

The Evolving Treatment Options for Diabetic Macular Edema
por: Jain, Atul, et al.
Publicado: (2013)

Current status of treatment of cancer-associated venous thromboembolism
por: Xiong, Wei
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ec1ohvvsh504novrv1kjgh4glj